Legend Biotech Corp Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Legend Biotech Corp (LEGN) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $586.60 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2026-03-10
- 2025-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $586.60M.
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $579.00M; Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised as first filed $579.03M.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $440.80M.
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $210.95M; Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised as first filed $190.13M.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised as first filed |
|---|---|---|
| 2025-12-31 | $586.60M 20-F · filed 2026-03-10 | |
| 2024-12-31 | $579.00M 20-F · filed 2026-03-10 | $579.03M 20-F · filed 2025-03-11 |
| 2023-12-31 | $440.80M 20-F · filed 2025-03-11 | |
| 2022-12-31 | $210.95M 20-F · filed 2024-03-19 | $190.13M 20-F · filed 2023-03-30 |
| 2021-12-31 | $15.42M 20-F · filed 2023-03-30 | $102.44M 20-F · filed 2022-03-31 |
| 2020-12-31 | $12.84M 20-F/A · filed 2023-02-17 | $74.41M 20-F · filed 2021-04-02 |
| 2019-12-31 | $59.40M 20-F · filed 2021-04-02 |